Wells D N
Reproductive Technologies Group, AgResearch Ruakura, East Street, PB 3123, Hamilton, New Zealand.
Rev Sci Tech. 2005 Apr;24(1):251-64.
An efficient animal cloning technology would provide many new opportunities for livestock agriculture, human medicine, and animal conservation. Nuclear cloning involves the production of animals that are genetically identical to the donor cells used in a technique known as nuclear transfer (NT). However, at present it is an inefficient process: in cattle, only around 6% of the embryos transferred to the reproductive tracts of recipient cows result in healthy, longterm surviving clones. Of concern are the high losses throughout gestation, during birth and in the post-natal period through to adulthood. Many of the pregnancy losses relate to failure of the placenta to develop and function correctly. Placental dysfunction may also have an adverse influence on postnatal health. These anomalies are probably due to incorrect epigenetic reprogramming of the donor genome following NT, leading to inappropriate patterns of gene expression during the development of clones. Whilst some physiological tests on surviving clones suggest normality, other reports indicate a variety of post-natal clone-associated abnormalities. This variability in outcome may reflect species-specific and/or cloning methodological differences. Importantly, to date it appears that these clone-associated phenotypes are not transmitted to offspring following sexual reproduction. This indicates that they represent epigenetic errors, rather than genetic errors, which are corrected during gametogenesis. Whilst this needs confirmation at the molecular level, it provides initial confidence in the first application of NT in agriculture, namely, the production of small numbers of cloned sires from genetically elite bulls, for natural mating, to effectively disseminate genetic gain. In addition to the animal welfare concerns with the technology, the underlying health of the animals and the consequential effect on food safety are critical aspects that require investigation to gain regulatory and consumer acceptance. Future improvements in animal cloning will largely arise from a greater understanding of the molecular mechanisms of reprogramming.
高效的动物克隆技术将为畜牧业、人类医学和动物保护带来许多新机遇。核克隆涉及生产与核移植(NT)技术中使用的供体细胞基因相同的动物。然而,目前这是一个效率低下的过程:在牛中,移植到受体母牛生殖道的胚胎中只有约6%能发育成健康且能长期存活的克隆体。令人担忧的是,在整个妊娠期、出生时以及出生后直至成年期都有很高的损失率。许多妊娠损失与胎盘发育和功能异常有关。胎盘功能障碍也可能对产后健康产生不利影响。这些异常可能是由于核移植后供体基因组的表观遗传重编程不正确,导致克隆体发育过程中基因表达模式异常。虽然对存活克隆体进行的一些生理测试表明其正常,但其他报告指出存在各种与克隆体相关的产后异常。结果的这种变异性可能反映了物种特异性和/或克隆方法的差异。重要的是,迄今为止,这些与克隆体相关的表型似乎不会在有性繁殖后传递给后代。这表明它们代表表观遗传错误,而非遗传错误,这些错误在配子发生过程中会得到纠正。虽然这需要在分子水平上得到证实,但它为核移植在农业中的首次应用——即从遗传优良的公牛中生产少量克隆种公牛用于自然交配以有效传播遗传增益——提供了初步信心。除了该技术引发的动物福利问题外,动物的潜在健康状况以及对食品安全的后续影响是需要调查以获得监管部门和消费者认可的关键方面。动物克隆未来的改进很大程度上将源于对重编程分子机制的更深入理解。